)
)
Abomics
)
Abomics is a Finnish health technology company specializing in pharmacogenetics (PGx). Founded in 2013 by medical doctors, we support healthcare professionals in making safer, more effective medication decisions by turning genetic data into actionable clinical insight.
Our pharmacogenetic solutions enable precision medication by identifying how individual genetic variation affects drug response and dosing. This reduces trial and error prescribing and lowers the risk of adverse drug reactions. Designed for real world healthcare settings, our solutions integrate seamlessly into existing clinical workflows, ensuring PGx information is available at the point of care throughout a patient’s lifetime.
Built on scientific evidence and clinical expertise, Abomics is a reliable partner to hospitals and clinics, laboratories, health IT providers, pharmaceutical companies, and biobanks globally. We work closely with our customers to deliver reliable, scalable, and customizable pharmacogenetic solutions that support personalized treatment.